MIM
HLVX

Monashee Investment Management’s HilleVax HLVX Stock Holding History

Monashee Investment Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-110,000
Closed -$1.48M – 65
2023
Q3 		$1.48M Buy
+110,000
New +$1.55M 0.62% 51

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Monashee Investment Management's HLVX Position: Q4 2023 in Review

Monashee Investment Management sold out of HilleVax (HLVX) in Q4 2023, closing a stake of 110,000 shares — an estimated $1.48M sold.

Monashee Investment Management first reported a position in HLVX in Q3 2023 and held it in 1 quarter. The position peaked at $1.48M in Q3 2023. 69 funds tracked by Wall St. Rank hold HLVX as of Q4 2023.

  • Monashee Investment Management reported no remaining HilleVax position as of Q4 2023 after selling out during the quarter.
  • Monashee Investment Management sold 110,000 HilleVax shares in Q4 2023, an estimated $1.48M.
  • Monashee Investment Management first reported a position in HilleVax in Q3 2023 and held it in 1 quarter.
  • Monashee Investment Management's HilleVax position peaked at $1.48M in Q3 2023.
  • 69 funds tracked by Wall St. Rank held HilleVax as of Q4 2023.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.